1、Frank R. Diabetic retinopathy and systemic factors[ J]. Middle East Afr
J Ophthalmol, 2015, 22(2): 151-156.Frank R. Diabetic retinopathy and systemic factors[ J]. Middle East Afr
J Ophthalmol, 2015, 22(2): 151-156.
2、Hietala K, Forsblom C, Summanen P, et al. Heritability of proliferative
diabetic retinopathy[ J]. Diabetes, 2008, 57(8): 2176-2180.Hietala K, Forsblom C, Summanen P, et al. Heritability of proliferative
diabetic retinopathy[ J]. Diabetes, 2008, 57(8): 2176-2180.
3、Patel A, MacMahon S, Chalmers J, et al. Effects of a fixed combination
of perindopril and indapamide on macrovascular and microvascular
outcomes in patients with type 2 diabetes mellitus (the ADVANCE
trial): a randomised controlled trial[ J]. Lancet, 2007, 370(9590):
829-840.Patel A, MacMahon S, Chalmers J, et al. Effects of a fixed combination
of perindopril and indapamide on macrovascular and microvascular
outcomes in patients with type 2 diabetes mellitus (the ADVANCE
trial): a randomised controlled trial[ J]. Lancet, 2007, 370(9590):
829-840.
4、Yau JW, Fau RS, Kawasaki R , et al. Global prevalence and major
risk factors of diabetic retinopathy[ J]. Diabetes Care, 2012, 35(3):
556-564.Yau JW, Fau RS, Kawasaki R , et al. Global prevalence and major
risk factors of diabetic retinopathy[ J]. Diabetes Care, 2012, 35(3):
556-564.
5、Wat N, Wong RL, Wong IY. A ssociations bet ween diabetic
retinopathy and systemic risk factors[ J]. Hong Kong Med J, 2016,
22(6): 589-599.Wat N, Wong RL, Wong IY. A ssociations bet ween diabetic
retinopathy and systemic risk factors[ J]. Hong Kong Med J, 2016,
22(6): 589-599.
6、Chou Y, Ma J, Su X, et al. Emerging insights into the relationship
between hyperlipidemia and the risk of diabetic retinopathy[ J]. Lipids
Health Dis, 2020, 19(1): 241.Chou Y, Ma J, Su X, et al. Emerging insights into the relationship
between hyperlipidemia and the risk of diabetic retinopathy[ J]. Lipids
Health Dis, 2020, 19(1): 241.
7、Sun Q, Jing Y, Zhang B, et al. The risk factors for diabetic retinopathy in
a Chinese population: a cross-sectional study[ J]. J Diabetes Res, 2021,
2021: 5340453.Sun Q, Jing Y, Zhang B, et al. The risk factors for diabetic retinopathy in
a Chinese population: a cross-sectional study[ J]. J Diabetes Res, 2021,
2021: 5340453.
8、Hanefeld M, Monnier L, Schnell O, et al. Early treatment with
basal insulin glargine in people with type 2 diabetes: lessons from
ORIGIN and other cardiovascular trials[ J]. Diabetes Ther, 2016,
7(2): 187-201.Hanefeld M, Monnier L, Schnell O, et al. Early treatment with
basal insulin glargine in people with type 2 diabetes: lessons from
ORIGIN and other cardiovascular trials[ J]. Diabetes Ther, 2016,
7(2): 187-201.
9、Almutairi N, Alahmadi S, Alharbi M, et al. The association between
HbA1c and other biomarkers with the prevalence and severity of
diabetic retinopathy[ J]. Cureus, 2021, 13(1): e12520.Almutairi N, Alahmadi S, Alharbi M, et al. The association between
HbA1c and other biomarkers with the prevalence and severity of
diabetic retinopathy[ J]. Cureus, 2021, 13(1): e12520.
10、Ashraf H, Faraz A, Ahmad J. Achievement of guideline targets of
glycemic and non-glycemic parameters in North Indian type 2 diabetes
mellitus patients: A retrospective analysis[ J]. Diabetes Metab Syndr,
2021, 15(1): 425-431.Ashraf H, Faraz A, Ahmad J. Achievement of guideline targets of
glycemic and non-glycemic parameters in North Indian type 2 diabetes
mellitus patients: A retrospective analysis[ J]. Diabetes Metab Syndr,
2021, 15(1): 425-431.
11、Aro A, Kauppinen A, Kivinen N, et al. Life style intervention improves
retinopathy status-the Finnish diabetes prevention study[ J]. Nutrients,
2019, 11(7): 1691.Aro A, Kauppinen A, Kivinen N, et al. Life style intervention improves
retinopathy status-the Finnish diabetes prevention study[ J]. Nutrients,
2019, 11(7): 1691.
12、Clarkson-Townsend D, Douglass A, Singh A, et al. Impacts of high fat
diet on ocular outcomes in rodent models of visual disease[ J]. Exp Eye
Res, 2021, 204: 108440.Clarkson-Townsend D, Douglass A, Singh A, et al. Impacts of high fat
diet on ocular outcomes in rodent models of visual disease[ J]. Exp Eye
Res, 2021, 204: 108440.
13、Busik J. Lipid metabolism dysregulation in diabetic retinopathy[ J]. J
Lipid Res, 2021, 62: 100017.Busik J. Lipid metabolism dysregulation in diabetic retinopathy[ J]. J
Lipid Res, 2021, 62: 100017.
14、Francisco A, Marbella P, Pedro I. Metabolic control and chronic
complications during a 3-year follow-up period in a cohort of type
2 diabetic patients attended in primary care in the Community of
Madrid[ J]. Endocrinol Nutr, 2014, 61(4): 11-17.Francisco A, Marbella P, Pedro I. Metabolic control and chronic
complications during a 3-year follow-up period in a cohort of type
2 diabetic patients attended in primary care in the Community of
Madrid[ J]. Endocrinol Nutr, 2014, 61(4): 11-17.
15、Li L, Lu J, Shuai H, et al. Decreased urine uric acid excretion is
associated with diabetic retinopathy but not with lower limb
atherosclerosis in hospitalized patients with type 2 diabetes[ J].
Atherosclerosis, 2015, 242(1): 13-18.Li L, Lu J, Shuai H, et al. Decreased urine uric acid excretion is
associated with diabetic retinopathy but not with lower limb
atherosclerosis in hospitalized patients with type 2 diabetes[ J].
Atherosclerosis, 2015, 242(1): 13-18.
16、Vanhoutte PM, Shimokawa H, Feletou M, et al. Endothelial dysfunction
and vascular disease - a 30th anniversary update[ J]. Physiol (Oxf ),
2017, 219(1): 22-96.Vanhoutte PM, Shimokawa H, Feletou M, et al. Endothelial dysfunction
and vascular disease - a 30th anniversary update[ J]. Physiol (Oxf ),
2017, 219(1): 22-96.
17、Merino M, Fortuny E, Joan RF, et al. Risk factors for diabetic
retinopathy in people with Type 2 diabetes: A case-control study in a
UK primary care setting[ J]. Prim Care Diabetes, 2016, 10(4): 300-308.Merino M, Fortuny E, Joan RF, et al. Risk factors for diabetic
retinopathy in people with Type 2 diabetes: A case-control study in a
UK primary care setting[ J]. Prim Care Diabetes, 2016, 10(4): 300-308.
18、Omae T, Nagaoka T, Yoshida A. Effects of habitual cigarette smoking
on retinal circulation in patients with type 2 diabetes[ J]. Invest
Ophthalmol Vis Sci, 2016, 57(3): 1345-1351.Omae T, Nagaoka T, Yoshida A. Effects of habitual cigarette smoking
on retinal circulation in patients with type 2 diabetes[ J]. Invest
Ophthalmol Vis Sci, 2016, 57(3): 1345-1351.
19、Maugeri G, D’Amico A, Rasà D, et al. Nicotine promotes blood retinal
barrier damage in a model of human diabetic macular edema[ J].
Toxicol In Vitro, 2017, 44: 182-189.Maugeri G, D’Amico A, Rasà D, et al. Nicotine promotes blood retinal
barrier damage in a model of human diabetic macular edema[ J].
Toxicol In Vitro, 2017, 44: 182-189.
20、Song YS, Nagaoka T, Omae T, et al. Systemic risk factors in bilateral
proliferative diabetic retinopathy requiring vitrectomy[ J]. Retina, 2016,
36(7): 1309-1313.Song YS, Nagaoka T, Omae T, et al. Systemic risk factors in bilateral
proliferative diabetic retinopathy requiring vitrectomy[ J]. Retina, 2016,
36(7): 1309-1313.